• 1
    Boyle P. Prostate-specific antigen (PSA) testing as screening for prostate cancer: the current controversy. Ann Oncol. 1998;9: 12634.
  • 2
    Barry MJ. PSA screening for prostate cancer: the current controversy – a viewpoint. Ann Oncol. 1998;9: 127982.
  • 3
    Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA. 1997;277: 46771.
  • 4
    The American Urological Association Prostate Cancer Clinical Guidelines Panel. Report on the Management of Clinically Localized Prostate Cancer. Baltimore, Md: American Urological Association Inc; 1995.
  • 5
    American Cancer Society Prostate Cancer Screening Guidelines. Cancer Facts and Figures 1997. Atlanta, Ga: American Cancer Society; 1997.
  • 6
    Executive Committee Report: Early Detection of Prostate Cancer. Baltimore, Md: American Urologic Association; 1997.
  • 7
    Kaplan RM. Shared medical decision-making: a new paradigm for behavioral medicine. Ann Behav Med. 1999;21: 311.
  • 8
    Frosch DL & Kaplan RM. Shared decision-making in clinical medicine: past research and future directions. Am J Prev Med. 1999;17: 28594.
  • 9
    Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11: 3429.
  • 10
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
  • 11
    Maxwell SE. Designing Experiments and Analyzing Data: A Model Comparison Perspective. Belmont, Calif: Wadsworth Publishers; 1990.
  • 12
    Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156: 13336.
  • 13
    Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8: 33340.
  • 14
    Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33: 77182.
  • 15
    Dartmouth Medical School, Center for the Evaluative Clinical Sciences. The Dartmouth Atlas of Health Care 1998. Dartmouth: American Hospital Association; 1998.
  • 16
    Morgan MW, Deber RB, Llewellyn-Thomas HA, et al. Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med. 2000;15: 68593.DOI: 10.1046/j.1525-1497.2000.91139.x
  • 17
    Kasper JF, Mulley AG, Wennberg JE. Developing shared decision-making programs to improve the quality of health care. QRB Qual Rev Bull. 1992;18: 18390.
  • 18
    Man-Son-Hing M, Laupacis A, O'Connor AM, Hart RG, Feldman G, Blackshear JL, Anderson DC. Development of a decision aid for patients with atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med. 2000;15: 72330.DOI: 10.1046/j.1525-1497.2000.90909.x